Pancreatic Cancer Research

ResearcherFirst Hospital of China Medical UniversityActive in the last 2 years

Zhongbo Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1935-5912; OpenAlex author ID A5101850938. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 3 papers · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 7

  1. Targeting PAK4 promotes Gemcitabine-induced pyroptosis in pancreatic cancer via NLRP1/caspase-3/GSDME axis. Co-author DOI 10.1038/s42003-026-09538-6↗
  2. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling. Co-author DOI 10.1186/s10020-022-00509-1↗
  3. ITGBL1 transcriptionally inhibited by JDP2 promotes the development of pancreatic cancer through the TGF-beta/Smad pathway. Co-author DOI 10.1590/1414-431x2022e11989↗
  4. Fzd7/Wnt7b signaling contributes to stemness and chemoresistance in pancreatic cancer. Co-author DOI 10.1002/cam4.3819↗
  5. Long non-coding RNA KTN1-AS1 promotes progression in pancreatic cancer through regulating microRNA-23b-3p/high-mobility group box 2 axis. Co-author DOI 10.18632/aging.203481↗
  6. Regulation of ABCG2 expression by Wnt5a through FZD7 in human pancreatic cancer cells. Co-author DOI 10.3892/mmr.2020.11690↗
  7. Identification of genes and pathways associated with pancreatic ductal adenocarcinoma by bioinformatics analyses. First author DOI 10.3892/ol.2015.4042↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuanhong Xu · 4 shared papers, 2016–2022 · strength 0.68
  2. Chenghai Zhao · 2 shared papers, 2021 · strength 0.41
  3. Yuanhong Xu · 1 shared paper, 2022 · strength 0.33
  4. Feng Li · 1 shared paper, 2026 · strength 0.32
  5. Xiaodong Tan · 1 shared paper, 2026 · strength 0.32
  6. Tianqi Lu · 1 shared paper, 2026 · strength 0.32
  7. Ning Liu · 1 shared paper, 2021 · strength 0.28
  8. Tiancong Du · 1 shared paper, 2022 · strength 0.19
  9. Jin Long · 1 shared paper, 2016 · strength 0.08
  10. Zhe Liu · 1 shared paper, 2016 · strength 0.08
  11. Chunlin Ge · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.